INMODE LTD

INMDNASDAQ

🏆 #2624 by market capEarnings Oct 28 · PreUS Equity

$14.22▲ $0.01 (+0.07%)

After hours · at close

🔔

Track INMD

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 0.1%

7d▼ 1.6%

14d▼ 4.5%

30d▼ 4.3%

ytd▼ 3.2%

1y▼ 5.1%

🏦Market Cap

$817M

Small Cap

📈Revenue Growth (YoY)

-6.2%

Declining

📊Gross Margin

76.5%

High

💵FCF Margin

23.3%

Strong

⚖️P/S Ratio

2.2x

Cheap

Otter Score

Fair

Trading Snapshot

Day Range: $14.04 – $14.33
52-Week Range: $12.72 – $16.74
Volume: $1.87B
Avg Volume: $1.34B
Shares Outstanding: 57.5M
Next Earnings: Oct 28, 2026

Fundamentals Snapshot

Annual Revenue: $370M
Last Q Revenue: $96M
P/E Ratio: 11.4
P/S Ratio: 2.2x
EPS (TTM): $1.32
Dividend Yield: 0.00%
Dilution (1yr): −12.0%

Why Investors Own INMD

✓High-growth profile — revenue up +16.4% YoY with expanding US Equity exposure.
✓Healthy economics — 53% gross margin and 28% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INMODE LTD

INMD

Financial Trends

Revenue

$370M▼ −6.2% YoY

Gross Margin

78.5%▼ −2.2% YoY

Operating Income

$85M▼ −24.1% YoY

Free Cash Flow

$84M▼ −36.1% YoY

Shares Outstanding

64.1M▼ −12.0% YoY

Net Cash

$289M▲ +$142M YoY

StockOtter · stockotter.space

About INMODE LTD

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

🦦